Enterprise AI

    Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin

    BMS scales its AI infrastructure with a second NVIDIA DGX SuperPOD to accelerate drug discovery and research.

    Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. And they’re doubling down. BMS announced today it is deployin...

    NB

    NVIDIA Blog

    Source

    NVIDIA Blog
    Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin
    AI Analysis

    Generated insight by OnAirToday AI

    Bristol Myers Squibb's investment in dedicated AI supercomputing infrastructure demonstrates a critical shift toward accelerating drug discovery timelines through massive-scale generative modeling. By leveraging high-performance computing clusters, the company is effectively industrializing pharmaceutical R&D to reduce the time and cost required to bring life-saving therapies to market.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at NVIDIA Blog →
    Share
    Filed under:Enterprise AI

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000